Gong L, Jin H, Li Y, Quan Y, et al. Rosiglitazone ameliorates skeletal muscle insulin resistance by decreasing free fatty acids release from adipocytes. Biochem Biophys Res Commun 2020;533:1122-1128.
PMID: 33036752